vs
Side-by-side financial comparison of 4D Molecular Therapeutics, Inc. (FDMT) and Ouster, Inc. (OUST). Click either name above to swap in a different company.
4D Molecular Therapeutics, Inc. is the larger business by last-quarter revenue ($85.1M vs $62.2M, roughly 1.4× Ouster, Inc.). On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 106.6%). 4D Molecular Therapeutics, Inc. produced more free cash flow last quarter ($28.5M vs $-37.2M). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 54.8%).
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
Ouster, Inc. is an American lidar technology company headquartered in San Francisco, California. It builds high-resolution, digital 3D lidar sensors for use in autonomous vehicles, industrial, robotics, drones, mapping, defense, and security systems.
FDMT vs OUST — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $85.1M | $62.2M |
| Net Profit | $19.4M | — |
| Gross Margin | — | 60.2% |
| Operating Margin | 17.3% | 1.5% |
| Net Margin | 22.8% | — |
| Revenue YoY | 8508900.0% | 106.6% |
| Net Profit YoY | 139.1% | — |
| EPS (diluted) | $0.43 | $0.10 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $85.1M | $62.2M | ||
| Q3 25 | $90.0K | $39.5M | ||
| Q2 25 | $15.0K | $35.0M | ||
| Q1 25 | $14.0K | $32.6M | ||
| Q4 24 | $1.0K | $30.1M | ||
| Q3 24 | $3.0K | $28.1M | ||
| Q2 24 | $5.0K | $27.0M | ||
| Q1 24 | $28.0K | $25.9M |
| Q4 25 | $19.4M | — | ||
| Q3 25 | $-56.9M | $-21.7M | ||
| Q2 25 | $-54.7M | $-20.6M | ||
| Q1 25 | $-48.0M | $-22.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-43.8M | $-25.6M | ||
| Q2 24 | $-35.0M | $-23.9M | ||
| Q1 24 | $-32.4M | $-23.8M |
| Q4 25 | — | 60.2% | ||
| Q3 25 | — | 42.1% | ||
| Q2 25 | — | 45.2% | ||
| Q1 25 | — | 41.3% | ||
| Q4 24 | — | 43.8% | ||
| Q3 24 | — | 38.3% | ||
| Q2 24 | — | 33.7% | ||
| Q1 24 | — | 28.6% |
| Q4 25 | 17.3% | 1.5% | ||
| Q3 25 | -67983.3% | -61.4% | ||
| Q2 25 | -396373.3% | -76.5% | ||
| Q1 25 | -383007.1% | -73.0% | ||
| Q4 24 | — | -85.1% | ||
| Q3 24 | -1704400.0% | -98.0% | ||
| Q2 24 | -849120.0% | -93.6% | ||
| Q1 24 | -136200.0% | -99.5% |
| Q4 25 | 22.8% | — | ||
| Q3 25 | -63195.6% | -55.0% | ||
| Q2 25 | -364386.7% | -58.8% | ||
| Q1 25 | -342657.1% | -67.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | -1461433.3% | -91.1% | ||
| Q2 24 | -699060.0% | -88.4% | ||
| Q1 24 | -115717.9% | -91.9% |
| Q4 25 | $0.43 | $0.10 | ||
| Q3 25 | $-1.01 | $-0.37 | ||
| Q2 25 | $-0.98 | $-0.38 | ||
| Q1 25 | $-0.86 | $-0.42 | ||
| Q4 24 | — | $-0.46 | ||
| Q3 24 | $-0.79 | $-0.54 | ||
| Q2 24 | $-0.63 | $-0.53 | ||
| Q1 24 | $-0.66 | $-0.55 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $402.7M | $208.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $505.7M | $261.7M |
| Total Assets | $566.7M | $349.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $402.7M | $208.6M | ||
| Q3 25 | $305.1M | $244.5M | ||
| Q2 25 | $293.2M | $226.5M | ||
| Q1 25 | $321.4M | $168.2M | ||
| Q4 24 | $424.9M | $172.0M | ||
| Q3 24 | $501.9M | $151.4M | ||
| Q2 24 | $541.9M | $184.2M | ||
| Q1 24 | $525.9M | $187.8M |
| Q4 25 | $505.7M | $261.7M | ||
| Q3 25 | $369.0M | $247.4M | ||
| Q2 25 | $420.9M | $221.0M | ||
| Q1 25 | $469.7M | $167.9M | ||
| Q4 24 | $510.6M | $180.9M | ||
| Q3 24 | $552.9M | $171.7M | ||
| Q2 24 | $588.3M | $170.6M | ||
| Q1 24 | $600.6M | $167.2M |
| Q4 25 | $566.7M | $349.5M | ||
| Q3 25 | $424.0M | $353.8M | ||
| Q2 25 | $473.6M | $321.8M | ||
| Q1 25 | $515.7M | $268.6M | ||
| Q4 24 | $560.4M | $276.1M | ||
| Q3 24 | $604.0M | $255.2M | ||
| Q2 24 | $620.1M | $309.9M | ||
| Q1 24 | $629.9M | $317.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.6M | $-15.4M |
| Free Cash FlowOCF − Capex | $28.5M | $-37.2M |
| FCF MarginFCF / Revenue | 33.5% | -59.8% |
| Capex IntensityCapex / Revenue | 0.1% | 35.0% |
| Cash ConversionOCF / Net Profit | 1.47× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-109.9M | $-64.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.6M | $-15.4M | ||
| Q3 25 | $-46.5M | $-18.3M | ||
| Q2 25 | $-43.4M | $-1.3M | ||
| Q1 25 | $-47.8M | $-4.9M | ||
| Q4 24 | $-134.6M | $-2.6M | ||
| Q3 24 | $-29.4M | $-3.8M | ||
| Q2 24 | $-30.2M | $-21.6M | ||
| Q1 24 | $-29.1M | $-5.7M |
| Q4 25 | $28.5M | $-37.2M | ||
| Q3 25 | $-46.6M | $-20.0M | ||
| Q2 25 | $-43.4M | $-2.2M | ||
| Q1 25 | $-48.4M | $-5.4M | ||
| Q4 24 | $-138.4M | $-4.0M | ||
| Q3 24 | $-31.2M | $-4.3M | ||
| Q2 24 | $-30.6M | $-22.0M | ||
| Q1 24 | $-29.8M | $-7.1M |
| Q4 25 | 33.5% | -59.8% | ||
| Q3 25 | -51765.6% | -50.7% | ||
| Q2 25 | -289620.0% | -6.3% | ||
| Q1 25 | -345635.7% | -16.6% | ||
| Q4 24 | -13837100.0% | -13.3% | ||
| Q3 24 | -1038966.7% | -15.4% | ||
| Q2 24 | -611840.0% | -81.5% | ||
| Q1 24 | -106421.4% | -27.4% |
| Q4 25 | 0.1% | 35.0% | ||
| Q3 25 | 101.1% | 4.3% | ||
| Q2 25 | 440.0% | 2.5% | ||
| Q1 25 | 4507.1% | 1.7% | ||
| Q4 24 | 378600.0% | 4.8% | ||
| Q3 24 | 59266.7% | 2.0% | ||
| Q2 24 | 6980.0% | 1.3% | ||
| Q1 24 | 2535.7% | 5.3% |
| Q4 25 | 1.47× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
